RACHEL BURNS: Open Payments
NPI 1730408857 · HAMBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 4 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $27 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
Products named: INGREZZA, CAPLYTA, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
